TDC
ACHV icon

Thompson Davis & Co’s Achieve Life Sciences ACHV Stock Holding History

Thompson Davis & Co’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12
Closed -$57K – 1184
2015
Q1 		$57K Buy
+12
New +$58.9K 0.07% 269

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Thompson Davis & Co's ACHV Position: Q2 2015 in Review

Thompson Davis & Co sold out of Achieve Life Sciences (ACHV) in Q2 2015, closing a stake of 12 shares — an estimated $57K sold.

Thompson Davis & Co first reported a position in ACHV in Q1 2015 and held it in 1 quarter. The position peaked at $57K in Q1 2015. 48 funds tracked by Wall St. Rank hold ACHV as of Q2 2015.

  • Thompson Davis & Co reported no remaining Achieve Life Sciences position as of Q2 2015 after selling out during the quarter.
  • Thompson Davis & Co sold 12 Achieve Life Sciences shares in Q2 2015, an estimated $57K.
  • Thompson Davis & Co first reported a position in Achieve Life Sciences in Q1 2015 and held it in 1 quarter.
  • Thompson Davis & Co's Achieve Life Sciences position peaked at $57K in Q1 2015.
  • 48 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2015.

Based on Thompson Davis & Co's 13F filing for Q2 2015, filed 24 Jul 2015.